ArticleOncotarget2016

The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo.

Gabriela Rozic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.